Literature DB >> 10773924

Neuroblastoma.

S Shah1, Y Ravindranath.   

Abstract

The neuroblastic tumours originate from primordial neural crest cells that normally develop into sympathetic nervous system, including the adrenal medulla. Neuroblastoma is the most intriguing pediatric neoplasm displaying diverse clinical and biologic characteristics and natural history. It has the highest rate of spontaneous regression of all human cancers, yet exhibits extremely malignant behaviour in older children with regional and disseminated disease. In the last 30 years, only a nominal improvement has occurred in the outlook of older children with metastatic disease at diagnosis. Tremendous gains in understanding of the biology of neuroblastoma in recent years have led to development of risk-related therapy based on age, stage and biological characteristics of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10773924     DOI: 10.1007/bf02731044

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  75 in total

1.  Neuroblastoma simulating acute leukemia.

Authors:  R B Raney; G M Lyon; F S Porter
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

2.  Radical surgery for abdominal neuroblastoma.

Authors:  E M Kiely
Journal:  Semin Surg Oncol       Date:  1993 Nov-Dec

3.  Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.

Authors:  P M Zeltzer; P J Marangos; A E Evans; S L Schneider
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

4.  A population-based study of the usefulness of screening for neuroblastoma.

Authors:  W G Woods; M Tuchman; L L Robison; M Bernstein; J M Leclerc; L C Brisson; J Brossard; G Hill; J Shuster; R Luepker; T Byrne; S Weitzman; G Bunin; B Lemieux
Journal:  Lancet       Date:  1996 Dec 21-28       Impact factor: 79.321

5.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

Review 6.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

7.  Prognostic factor in neuroblastoma.

Authors:  A E Evans; G J D'Angio; K Propert; J Anderson; H W Hann
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

Authors:  A Nakagawara; M Arima-Nakagawara; N J Scavarda; C G Azar; A B Cantor; G M Brodeur
Journal:  N Engl J Med       Date:  1993-03-25       Impact factor: 91.245

10.  Correlating telomerase activity levels with human neuroblastoma outcomes.

Authors:  E Hiyama; K Hiyama; T Yokoyama; Y Matsuura; M A Piatyszek; J W Shay
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

View more
  2 in total

1.  TP53BP2 decreases cell proliferation and induces autophagy in neuroblastoma cell lines.

Authors:  Yi Pang; Lianhong Pan; Yonghui Zhang; Guiyuan Liu
Journal:  Oncol Lett       Date:  2019-03-15       Impact factor: 2.967

2.  Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells.

Authors:  Xiao-Xue Ke; Dunke Zhang; Shunqin Zhu; Qingyou Xia; Zhonghuai Xiang; Hongjuan Cui
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.